Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-23-014126
Filing Date
2023-02-24
Accepted
2023-02-24 07:55:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ea174177-13ggrisard_nlsphar.htm SC 13G 46721
  Complete submission text file 0001213900-23-014126.txt   47967
Mailing Address THE CIRCLE 6 8058 ZURICH V8 CH-6370
Business Address THE CIRCLE 6 8058 ZURICH V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Subject) CIK: 0001783036 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92065 | Film No.: 23662382
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NLS PHARMACEUTICS LTD. THE CIRCLE 6 ZURICH V8 8058
Business Address
Grisard Felix (Filed by) CIK: 0001966808 (see all company filings)

Type: SC 13G